Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Neoplasms × Oxycodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 59 pembrolizumab 52 Cetuximab 51 Oxaliplatin 49 Bevacizumab 49 Irinotecan 48 Leucovorin 47 Capecitabine 25 Nivolumab 19 Gemcitabine 16 Cisplatin 16 IFL protocol 15 Folfox protocol 15 Carboplatin 15 atezolizumab 14 Specimen Handling 14 Paclitaxel 14 Cyclophosphamide 14 Biopsy 13 Magnetic Resonance Spectroscopy 12 trifluridine tipiracil drug combination 11 Pemetrexed 10 spartalizumab 9 regorafenib 9 trametinib 8 130-nm albumin-bound paclitaxel 8 fludarabine 7 durvalumab 7 Trifluridine 7 dehydroftorafur 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03253133 2023-05-03

NIPOX

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡